In Brief: NutraGenics
This article was originally published in The Tan Sheet
Executive Summary
NutraGenics: Receives a $5 mil. "private placement" from a group of Asian investors in exchange for 1 mil. shares of restricted common stock, the Phoenix-based company announces. Proceeds will be used for the national launch of NutraGenics' first dietary supplement product during the first quarter of 1997. The product is derived from rice and has been shown in animal tests to "promote normal cardiovascular circulation by altering cholesterol metabolism and providing a high degree of anti-oxidation protection in the blood," NutraGenics claims...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning